IGF::OT::IGF SMARTT NON-BIOLOGICS AND SMALL MOLECULE PF; BASE PERIOD; FY16; AMT $ 1,175,069; CAN 8470205

IGF::OT::IGF SMARTT 非生物制剂和小分子 PF；

• 批准号: 10905960
• 负责人: NA NA
• 金额: $ 1.76万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-03-01 至 2019-02-07
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10905960
• 关键词: Address; Collaborations; Communication; Disease; Education; Family; Fostering; Government Agencies; Health; Health Professional; Heart Diseases; Hematological Disease; Individual; Industry; Institution; International; Leadership; Lung diseases; Mentors; National Heart, Lung, and Blood Institute; Patients; Physicians; Prevention; Privatization; Professional Organizations; Public Health; Research; Research Infrastructure; Resources; Scientist; Training; Translations; base; clinical practice; community organizations; patient advocacy group; programs; small molecule

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.

国家心脏，肺和血液研究所（NHLBI）为研究，培训和教育计划提供全球领导，以促进心脏，肺和血液疾病的预防和治疗，并增强所有人的健康，使他们能够活得更长，更充实的生活。